Tessera Defense and Homeland Security has integrated autonomous Open-Source Intelligence (OSINT) capabilities into its physical security platform. This enhancement allows the platform to detect emerging risks, analyze suspicious activities using public data, and initiate preventive security measures before threats materialize. The system connects external intelligence with cameras, sensors, and access controls to assess risks beyond physical perimeters, improving response times and decision-making. Tessera plans to further expand its intelligence sources, including ELINT, SIGINT, and PHYSINT, to strengthen its security solutions across critical infrastructure and homeland security sectors.
Tessera Defense and Homeland Security's integration of autonomous OSINT capabilities comes as 101 out of 150 Technology-sector US stocks on Pluang rose today. For readers following this sector, here is Pluang's market snapshot as of Oct 19, 2026 18:31 WIB: Credo Technology Group Holding Ltd (CRDO) increased by 4.29% to USD 176.98 with a typical hold time of 23 days, ASE Technology Holding Co Ltd (ASX) rose 4.17% to USD 41.18 with a typical hold time of 49 days, and Lam Research Corporation (LRCX) gained 4.16% to USD 274.91 with a typical hold time of 61 days.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
